These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6540685)

  • 1. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
    Elliott JA; Ahmedzai S; Hole D; Dorward AJ; Stevenson RD; Kaye SB; Banham SW; Stack BH; Calman KC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1025-32. PubMed ID: 6540685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
    Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J
    Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
    González Larriba JL; Alberola V; Lianes P; Panizo A; Carrato A; Muñoz Quintana A; Cardenal F; Gracia JM; Moyano A; Díaz-Rubio E
    Rev Clin Esp; 1994 Nov; 194(11):953-9. PubMed ID: 7846351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
    Gralla RJ; Casper ES; Kelsen DP; Braun DW; Dukeman ME; Martini N; Young CW; Golbey RB
    Ann Intern Med; 1981 Oct; 95(4):414-20. PubMed ID: 7025719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
    Itri LM; Gralla RJ; Kelsen DP; Chapman RA; Casper ES; Braun DW; Howard JE; Golbey R; Heelan RT
    Cancer; 1983 Mar; 51(6):1050-5. PubMed ID: 6185210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
    Gatzemeier U; Zschaber R; Hossfeld DK; Radenbach D
    Onkologie; 1984 Oct; 7(5):308-15. PubMed ID: 6392971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
    Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
    J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
    J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
    Le Chevalier T; Brisgand D; Soria JC; Douillard JY; Pujol JL; Ruffie P; Aberola V; Cigolari S
    Oncologist; 2001; 6 Suppl 1():8-11. PubMed ID: 11181998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
    Le Chevalier T; Brisgand D; Pujol JL; Douillard JY; Monnier A; Rivière A; Chomy P; Le Groumellec A; Ruffie P; Gottfried M; Gaspard MH; Chevreau C; Alberola V; Cigolari S; Besson F; Martinez A; Besenval M; Berthaud P; Tursz T
    Bull Cancer; 1996 May; 83(5):385-94. PubMed ID: 8680091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ; Arnold E; Walter M; Sander U
    Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
    Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
    Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
    Niederle N; Schütte J; Krischke W; Seeber S; Schmidt CG
    Klin Wochenschr; 1984 Aug; 62(16):783-6. PubMed ID: 6090762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial of combination vindesine and cisplatin versus single-agent vindesine in advanced non-small cell lung cancer.
    Popkin JD; Hong WK; Cersosimo RJ; Faling LJ; Snow MN; Fofonoff SA
    Pharmacotherapy; 1985; 5(1):20-2. PubMed ID: 3885173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
    Jelić S; Mitrović L; Radosavljević D; Elezar E; Babović N; Kovcin V; Tomasević Z; Kovacević S; Gavrilović D; Radulović S
    Lung Cancer; 2001 Oct; 34(1):1-13. PubMed ID: 11557107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.